A community from Nature Biomedical Engineering
Menu

Nature Portfolio Bioengineering Community

  • Register
  • Sign In
Go to the profile of Alex Zhavoronkov

Alex Zhavoronkov (They/Them)

Founder and CEO, Insilico Medicine
Contact Follow
  • Insilico Medicine
  • Hong Kong
  • Profile
  • Content 4
  • Contributions 1
  • All content
  • Posts
  • Videos
  • Documents
From Paper to Industrial-scale Platform: a 7-year Behind the Paper Journey from iPANDA to PandaOmics AI-Powered Target Discovery Platform
Contributor Nature Comms
After the Paper

From Paper to Industrial-scale Platform: a 7-year Behind the Paper Journey from iPANDA to PandaOmics AI-Powered Target Discovery Platform

Go to the profile of Alex Zhavoronkov +3
Alex Zhavoronkov and 3 others
Sep 13, 2022
Using nanotechnology to improve cancer therapy
Contributor Nature Comms
Behind the Paper

Using nanotechnology to improve cancer therapy

Go to the profile of Alex Zhavoronkov +2
Alex Zhavoronkov and 2 others
Sep 08, 2022
From Paper to Industrial-scale Platform: a 3-Year Behind the Paper Journey from GENTRL to Chemistry42
Contributor
Nature Biotech
After the Paper

From Paper to Industrial-scale Platform: a 3-Year Behind the Paper Journey from GENTRL to Chemistry42

Go to the profile of Alex Zhavoronkov +2
Alex Zhavoronkov and 2 others
Aug 17, 2022
Molecules "imagined" using advanced artificial intelligence show promising results in pre-clinical experiments
Contributor
Nature Biotech
Behind the Paper

Molecules "imagined" using advanced artificial intelligence show promising results in pre-clinical experiments

Go to the profile of Alex Zhavoronkov
Alex Zhavoronkov
Sep 02, 2019

This community is not edited and does not necessarily reflect the views of Springer Nature (of which Nature Portfolio is part). Springer Nature makes no representations, warranties or guarantees, whether express or implied, that the content on this community is accurate, complete or up to date, and to the fullest extent permitted by law all liability is excluded.

  • Website Terms of Use
  • Privacy notice
  • Cookie policy
  • Report content
Copyright © 2023 Springer Nature All rights reserved. Powered by Zapnito.
Nature Portfolio Bioengineering Community
Nature Portfolio Bioengineering Community
  • Home
  • Channels
    • Back
    • Behind the Paper
    • Nature Biotech 25th Anniversary
    • From the Editors
    • Journal Club
    • News and Opinion
    • After the Paper
    • On the Road
    • From Cover to Cover
    • About the Community
    • Journal surgery
    • Trade secrets
    • COVID-19
  • Community policy
  • More about the Community
  • Account
  • Register
  • Sign In
  • Social
  • Instagram

Cookies

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website. You can decide for yourself which categories you want to deny or allow. Please note that based on your settings not all functionalities of the site are available.

Further information can be found in our privacy policy.

Cookie Control

Customise your preferences for any tracking technology

The following allows you to customize your consent preferences for any tracking technology used to help us achieve the features and activities described below. To learn more about how these trackers help us and how they work, refer to the cookie policy. You may review and change your preferences at any time.

See the full cookie policy See the full privacy policy
More information

These trackers are used for activities that are strictly necessary to operate or deliver the service you requested from us and, therefore, do not require you to consent.

More information

These trackers help us to deliver personalized marketing content and to operate, serve and track ads.

More information

These trackers help us to deliver personalized marketing content to you based on your behaviour and to operate, serve and track social advertising.

More information

These trackers help us to measure traffic and analyze your behaviour with the goal of improving our service.

More information

These trackers help us to provide a personalized user experience by improving the quality of your preference management options, and by enabling the interaction with external networks and platforms.